Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Sector Catalysts

SPR

The U.S. emergency oil stockpile whose releases and refills swing crude prices and energy stocks.

Also known as: Strategic Petroleum Reserve

What it is
The Strategic Petroleum Reserve is the U.S. government's emergency crude oil stockpile held in underground salt caverns. The government can release barrels to calm prices or refill to rebuild stocks. It is a policy lever on the oil market.
What it does
Large SPR releases add supply and can pressure crude prices, while refill programs create a demand floor. Investors read SPR policy for crude-price direction affecting producers and refiners. It is a government hand on a commodity market.
The evidence
Coordinated SPR releases have been used to counter oil-price spikes, with refill announcements later seen as demand support.
Best for
Oil producers and refiners: XOM, CVX, OXY, VLO; ETF XLE.
Pairs well with
sanctions, lng-export-permit, ira-tax-credits
Use cautiously with
The SPR is small relative to global demand; overrating its ability to control prices can lead to bad crude bets.
Cautions
Releases are temporary and can be swamped by OPEC decisions and demand shifts.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More sector catalysts

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →